Published in Carcinogenesis on January 01, 1990
Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res (2011) 0.95
Choline's role in maintaining liver function: new evidence for epigenetic mechanisms. Curr Opin Clin Nutr Metab Care (2013) 0.85
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet (2001) 3.76
Role of nutrition in immunologic function. Physiol Rev (1980) 1.94
Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst (1999) 1.92
Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res (1967) 1.82
Genotyping by mass spectrometric analysis of short DNA fragments. Nat Biotechnol (1998) 1.76
In vitro reactions of aflatoxin B1-adducted DNA. Proc Natl Acad Sci U S A (1981) 1.73
Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res (1969) 1.71
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A (1993) 1.71
Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A (2001) 1.54
Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem Res Toxicol (1999) 1.52
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res (2001) 1.51
Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc Natl Acad Sci U S A (1998) 1.45
Zinc: health effects and research priorities for the 1990s. Environ Health Perspect (1994) 1.42
Overnutrition on resistance of dogs to distemper virus. Fed Proc (1967) 1.39
Effect of infection on skeletal muscle ribosomes in rats fed adequate or low protein. J Nutr (1968) 1.36
Sequential morphologic changes in aflatoxin B carcinogenesis in the rat. Cancer Res (1968) 1.33
Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther (1999) 1.32
The role of diet and the reticuloendothelial system in the response of rats to Salmonella typhilmurium infection. Br J Exp Pathol (1968) 1.32
DNA damage by mycotoxins. Mutat Res (1999) 1.29
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res (1987) 1.27
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis (1995) 1.25
Depressed cell-mediated immunity in megaloblastic anemia due to folic acid deficiency. Am J Clin Nutr (1975) 1.23
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis (1988) 1.23
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res (2001) 1.22
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.21
Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev (2001) 1.20
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res (1992) 1.19
Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. Cancer Res (1980) 1.18
Dietary enhancement of intestinal carcinogenesis by dimethylhydrazine in rats. Nature (1974) 1.17
Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci U S A (1985) 1.17
Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A. Cancer Res (1973) 1.16
Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res (1991) 1.15
Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A (1981) 1.14
Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis (1994) 1.11
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res (1986) 1.11
Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin Pharmacol Ther (1993) 1.09
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev (1997) 1.09
Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. Cancer Res (1971) 1.09
Tumorigenicity of fluoranthene in a newborn mouse lung adenoma bioassay. Carcinogenesis (1984) 1.08
Mycotoxins: toxicity, carcinogenicity, and the influence of various nutritional conditions. Environ Health Perspect (1974) 1.07
Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Res (1982) 1.06
Functional characteristics of lymphocytes isolated from the rat large intestine. Response to T-cell mitogens and natural killer cell activity. Gastroenterology (1984) 1.05
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis (1996) 1.05
Zinc deficiency and methylbenzylnitrosamine-induced esophageal cancer in rats. J Natl Cancer Inst (1978) 1.04
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res (2001) 1.02
Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis (1999) 1.02
Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis (1992) 1.02
Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet Toxicol (1974) 1.02
Vitamins and cancer prevention: issues and dilemmas. Cancer (1981) 1.01
Labile methyl groups and the promotion of cancer. Annu Rev Nutr (1986) 1.01
Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis (1985) 1.00
Carcinogenicity in rats of the nitrosated bile acid conjugates N-nitrosoglycocholic acid and N-nitrosotaurocholic acid. Cancer Res (1985) 1.00
High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc Natl Acad Sci U S A (1984) 1.00
Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res (1985) 1.00
Nitrite promotes lymphoma incidence in rats. Science (1979) 0.99
Morphology and distribution of 1,2-dimethylhydrazine dihydrochloride-induced colon tumors and their relationship to gut-associated lymphoid tissue in the rat. J Natl Cancer Inst (1984) 0.98
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis (1999) 0.98
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer (1999) 0.97
Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res (1996) 0.96
The FEMA GRAS assessment of pyrazine derivatives used as flavor ingredients. Flavor and Extract Manufacturers Association. Food Chem Toxicol (2002) 0.96
Nutrition and immunological responsiveness. T-cell function in the offspring of lipotrope and protein-deficient rats. Immunology (1974) 0.96
The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis (1990) 0.95
Renal damage associated with silicon compounds in dogs. Proc Natl Acad Sci U S A (1970) 0.95
Vitamin A and benzo(a)pyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet. Cancer Res (1975) 0.95
Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci (2001) 0.95
Environmental tobacco smoke exposure in inner-city children. Cancer Epidemiol Biomarkers Prev (1996) 0.94
Acute toxicity of aflatoxin B1 in the dog. Pathol Vet (1966) 0.93
Rat colon carcinomas associated with aflatoxin and marginal vitamin A. J Natl Cancer Inst (1973) 0.93
Aflatoxin and liver cancer. Baillieres Best Pract Res Clin Gastroenterol (1999) 0.93
Chronic aflatoxicosis. J Am Vet Med Assoc (1973) 0.93
Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr Cancer (1993) 0.92
Biomarkers and mechanistic approaches in environmental epidemiology. Annu Rev Public Health (1995) 0.92
Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Chem Res Toxicol (2001) 0.92
Nutrition and aflatoxin carcinogenesis. Nature (1971) 0.92
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiol Biomarkers Prev (1997) 0.92
Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Carcinogenesis (1996) 0.91
Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli. J Bacteriol (1988) 0.91
Mass spectrometry for genotyping: an emerging tool for molecular medicine. Mol Med Today (2000) 0.91
I. Depressed immunological function in zinc-deprived rats as measured by mitogen response of spleen, thymus, and peripheral blood. Am J Clin Nutr (1979) 0.91
Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis (1992) 0.91
Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat. Toxicol Appl Pharmacol (1988) 0.91
Inhibition of aflatoxin carcinogenesis by diethylstilbestrol in male rats. Arch Environ Health (1969) 0.90
Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. Chem Res Toxicol (2001) 0.89
Antibody-antigen binding in organic solvents. Biochem Biophys Res Commun (1989) 0.89
Effects of cirrhosis and other liver insults on induction of liver tumors by aflatoxin in rats. Lab Invest (1966) 0.89
Transplantation studies on induced and spontaneous nodules from B6C3F1 mouse liver. Toxicol Pathol (1984) 0.89
Animal model of human disease. Adenocarcinoma of the colon. Am J Pathol (1973) 0.89
Influence of pharmacological experiments of chemicals and other factors in diets of laboratory animals. Fed Proc (1975) 0.88
Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis (1993) 0.88
Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Chem Res Toxicol (1992) 0.88
Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis (1995) 0.88
The induction of liver cirrhosis in rats by purified amino acid diets. Cancer Res (1969) 0.88
Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res (1993) 0.88
A semisynthetic diet for long-term maintenance of hamsters to study effects of dietary vitamin A. Lab Anim Sci (1974) 0.88
Experimental hepatocellular carcinogenesis. Cancer Res (1976) 0.87
Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels. Environ Health Perspect (1996) 0.87
Nutrition and cancer: a review, with emphasis on the role of vitamins C and E and selenium. Nutr Cancer (1983) 0.87
Approaches to environmental exposure assessment in children. Environ Health Perspect (1998) 0.87